Literature DB >> 17717853

Vaccination to prevent zoster in the elderly.

A A Gershon.   

Abstract

Mesh:

Substances:

Year:  2007        PMID: 17717853      PMCID: PMC2870665          DOI: 10.1017/s0950268807008849

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


× No keyword cloud information.
  9 in total

Review 1.  Use of varicella vaccines to prevent herpes zoster in older individuals.

Authors:  M J Levin
Journal:  Arch Virol Suppl       Date:  2001

2.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

Review 3.  Recommendations for the management of herpes zoster.

Authors:  Robert H Dworkin; Robert W Johnson; Judith Breuer; John W Gnann; Myron J Levin; Miroslav Backonja; Robert F Betts; Anne A Gershon; Maija L Haanpaa; Michael W McKendrick; Turo J Nurmikko; Anne Louise Oaklander; Michael N Oxman; Deborah Pavan-Langston; Karin L Petersen; Michael C Rowbotham; Kenneth E Schmader; Brett R Stacey; Stephen K Tyring; Albert J M van Wijck; Mark S Wallace; Sawko W Wassilew; Richard J Whitley
Journal:  Clin Infect Dis       Date:  2007-01-01       Impact factor: 9.079

4.  Shingles vaccine: effective and costly or cost-effective?

Authors:  Jeffrey P Koplan; Rafael Harpaz
Journal:  Ann Intern Med       Date:  2006-09-05       Impact factor: 25.391

5.  Live vaccine used to prevent the spread of varicella in children in hospital.

Authors:  M Takahashi; T Otsuka; Y Okuno; Y Asano; T Yazaki
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

6.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

7.  Postherpetic neuralgia.

Authors:  R E Hope-Simpson
Journal:  J R Coll Gen Pract       Date:  1975-08

8.  Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  John Hornberger; Katherine Robertus
Journal:  Ann Intern Med       Date:  2006-09-05       Impact factor: 25.391

9.  Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged.

Authors:  R Berger; G Florent; M Just
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

  9 in total
  1 in total

1.  Prevalence and healthcare utilization of herpes zoster and postherpetic neuralgia in South Korea: disparity among patients with different immune statuses.

Authors:  Chelim Cheong; Tae-Jin Lee
Journal:  Epidemiol Health       Date:  2014-08-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.